Usability and Acceptance of a New Robotic Exoskeleton for Shoulder Rehabilitation
CRMINAIL08
Motor Rehabilitation of the Shoulder Complex After Orthopaedic Injury or Surgery Because of Work Accidents: a Pilot Study.
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this pilot study is to validate the safety, reliability and usability of FLOAT medical device, a prototypal robotic system for the rehabilitation of the shoulder, designed and developed in the Rehab Technologies IIT-INAIL Lab to fulfil the needs orthopaedic conditions. The acceptance from patients and therapists will be assessed after a single session of robotic therapy in a sample of injured workers suffering from post-traumatic or post-surgical shoulder disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2020
CompletedFirst Submitted
Initial submission to the registry
February 9, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2022
CompletedMarch 31, 2022
March 1, 2022
1.3 years
February 9, 2021
March 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of adverse events
The physiotherapist is required to report any adverse events occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the safety of the device
1 year
Number of device malfunctions
The physiotherapist is required to report any malfunctions occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the reliability of the device
1 year
Secondary Outcomes (6)
Numeric Pain Rating Scale (NPRS)
1 year
The Borg Category-Ratio Scale (CR-10)
1 year
Ad-hoc questionnaires for the patient, one for each of the three modalities (for a total amount of 3 questionnaires)
After the completion of the testing session with each of the three modalities
Ad-hoc questionnaires for the therapist, one for each of the three modalities (for a total amount of 3 questionnaires)
1 year
Ad-hoc questionnaire for the patient (final evaluation)
1 year (at the end of the study)
- +1 more secondary outcomes
Study Arms (1)
Experimental
EXPERIMENTALSix subjects are involved in a single session of upper limb robotic-assisted therapy lasting about 3 hours and including: * passive mobilization of patient's upper arm along elementary shoulder movements:shoulder flexion/extension, adduction/ abduction in the frontal plane, horizontal adduction/ abduction, intra/extrarotation (Passive Mode); * passive mobilization of patient's upper arm along complex trajectories recorded from manual mobilization of the therapist (Learn\&Replay Mode); * active mobilization, performed by the patient during rehabilitative functional tasks, relying only on gravity and friction compensations and tuneable assistance from the exoskeleton (Transparency Mode).
Interventions
The FLOAT device is composed by a wearable exoskeleton assembled on a poly-articulated arm that, in turn, is mounted on a support base with unlockable wheels. The exoskeleton includes 5 motors arranged in a way that, when generating movement, ensures the optimal involvement of all the articulations of the shoulder complex, particularly the glenohumeral and the scapulothoracic joints. According to the chosen modality of use of the exoskeleton, the device allows patient's passive or active-assisted mobilization. The poly-articulated arm supporting the exoskeleton is capable to compensate exoskeleton weight in every configuration and, if configured appropriately, permits exoskeleton use both in seated and standing positions. The support base of the device has unlockable wheels that, if unlocked, permit the free movement of the patient in the workspace, enabling the performance of more complex functional activities while assisted by the exoskeleton.
Eligibility Criteria
You may qualify if:
- Height between 160 and 185 cm;
- Distance between the shoulder joint center and the sagittal plane between 156 and 197 mm;
- Shoulder joint center to wall distance between 82 and 142 mm
- Maximum shoulter radius: 120 mm
- Distance between the shoulder joint center and the elbow joint center between 250 and 303 mm
- Time from acute event ≥ 60 days
- Right shoulder joint disfunction after orthopaedic injury or surgery as a result of work accidents
- Post-immobilization phase
- At least 80° shoulder passive flexion and 45° shoulder passive abduction
- Pain intensity on movement \< 6 NRS;
You may not qualify if:
- Glenohumeral joint instability
- Shoulder Prosthetic implants
- Upper arm sensorimotor deficits
- Chronic inflammatory disorder involving upper arm joints
- Pseudoarthrosis of the proximal humerus fractures
- Spinal fractures within the last 3 months
- Open skin at the level of the patient-device interface
- Current or prior history of malignancy
- Pregnancy or breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
INAIL - Centro di Riabilitazione Motoria di Volterra
Volterra, Pisa, 56048, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisa Taglione, MD
Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2021
First Posted
February 17, 2021
Study Start
November 20, 2020
Primary Completion
February 21, 2022
Study Completion
February 21, 2022
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share